Literature DB >> 17258216

Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats.

M Mlynarik1, D Zelena, G Bagdy, G B Makara, D Jezova.   

Abstract

Vasopressin, a peptide hormone functioning also as a neurotransmitter, neuromodulator and regulator of the stress response is considered to be one of the factors related to the development and course of depression. In the present study, we have tested the hypothesis that congenital deficit of vasopressin in Brattleboro rats leads to attenuated depression-like behavior in tests modeling different symptoms of depression. In addition, hypothalamic-pituitary-adrenocortical axis activity was investigated. Vasopressin deficient rats showed signs of attenuated depression-like behavior in forced swimming and sucrose preference tests, while their behavior on elevated plus maze was unchanged. Vasopressin deficiency had no influence on basal levels of ACTH and corticosterone and had only mild impact on hormonal activation in response to forced swimming and plus-maze exposure. However, vasopressin deficient animals showed higher level of dexamethasone induced suppression of corticosterone response to restraint stress and higher basal levels of corticotropin-releasing hormone mRNA in the hypothalamic paraventricular nucleus. In conclusion, present data obtained in vasopressin deficient rats show that vasopressin is involved in the development of depression-like behavior, in particular of the coping style and anhedonia. Moreover, behavioral and endocrine responses were found to be dissociated. We suggest that brain vasopressinergic circuits distinct from those regulating the HPA axis are involved in generating depression-like behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17258216     DOI: 10.1016/j.yhbeh.2006.12.007

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  17 in total

Review 1.  Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats.

Authors:  Jana Bundzikova; Zdeno Pirnik; Dora Zelena; Jens D Mikkelsen; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.046

2.  Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.

Authors:  Chad E Beyer; Jason M Dwyer; Brian J Platt; Sarah Neal; Bin Luo; Huai-Ping Ling; Qian Lin; Robert J Mark; Sharon Rosenzweig-Lipson; Lee E Schechter
Journal:  Psychopharmacology (Berl)       Date:  2010-03-12       Impact factor: 4.530

Review 3.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

4.  G9a-Mediated Regulation of OXT and AVP Expression in the Basolateral Amygdala Mediates Stress-Induced Lasting Behavioral Depression and Its Reversal by Exercise.

Authors:  Tae-Kyung Kim; Jung-Eun Lee; Ji-Eun Kim; Jin-Young Park; Juli Choi; Hannah Kim; Eun-Hwa Lee; Pyung-Lim Han
Journal:  Mol Neurobiol       Date:  2015-04-12       Impact factor: 5.590

5.  Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts.

Authors:  Yair J Ben-Efraim; Danuta Wasserman; Jerzy Wasserman; Marcus Sokolowski
Journal:  Neuropsychopharmacology       Date:  2013-02-19       Impact factor: 7.853

6.  Attenuated stress response to acute restraint and forced swimming stress in arginine vasopressin 1b receptor subtype (Avpr1b) receptor knockout mice and wild-type mice treated with a novel Avpr1b receptor antagonist.

Authors:  J A Roper; M Craighead; A-M O'Carroll; S J Lolait
Journal:  J Neuroendocrinol       Date:  2010-11       Impact factor: 3.627

Review 7.  Depression and antidepressants: molecular and cellular aspects.

Authors:  Cristina Lanni; Stefano Govoni; Adele Lucchelli; Cinzia Boselli
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261

Review 8.  Vasopressin: behavioral roles of an "original" neuropeptide.

Authors:  Heather K Caldwell; Heon-Jin Lee; Abbe H Macbeth; W Scott Young
Journal:  Prog Neurobiol       Date:  2007-11-04       Impact factor: 11.685

9.  Arginine vasopressin (AVP) expressional changes in the hypothalamic paraventricular and supraoptic nuclei of stroke-prone spontaneously hypertensive rats.

Authors:  Sun Shin Yi; Hyun-Jin Kim; Seon-Gil Do; Yoon-Bok Lee; Hee Jin Ahn; In Koo Hwang; Yeo Sung Yoon
Journal:  Anat Cell Biol       Date:  2012-06-30

Review 10.  Vasopressin V1B Receptor Antagonists as Potential Antidepressants.

Authors:  Shigeyuki Chaki
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.